Subgroup analysis showed that serum adiponectin concentration remained significantly lower in GDM patients compared to their BMI matched control subjects (P < 0.00001, [WMD] = −2.66 μg/mL, 95% CI [−2.85, −2.48]  μg/mL). This evidence concerns the gene ADIPOQ and gestational diabetes.